333 related articles for article (PubMed ID: 36964659)
1. CRISPR-Cas-mediated transcriptional modulation: The therapeutic promises of CRISPRa and CRISPRi.
Bendixen L; Jensen TI; Bak RO
Mol Ther; 2023 Jul; 31(7):1920-1937. PubMed ID: 36964659
[TBL] [Abstract][Full Text] [Related]
2. Targeted regulation of transcription in primary cells using CRISPRa and CRISPRi.
Jensen TI; Mikkelsen NS; Gao Z; Foßelteder J; Pabst G; Axelgaard E; Laustsen A; König S; Reinisch A; Bak RO
Genome Res; 2021 Nov; 31(11):2120-2130. PubMed ID: 34407984
[TBL] [Abstract][Full Text] [Related]
3. Systematic Evaluation of CRISPRa and CRISPRi Modalities Enables Development of a Multiplexed, Orthogonal Gene Activation and Repression System.
Martella A; Firth M; Taylor BJM; Göppert A; Cuomo EM; Roth RG; Dickson AJ; Fisher DI
ACS Synth Biol; 2019 Sep; 8(9):1998-2006. PubMed ID: 31398008
[TBL] [Abstract][Full Text] [Related]
4. CRISPR Interference and Activation to Modulate Transcription in Yarrowia lipolytica.
Misa J; Schwartz C
Methods Mol Biol; 2021; 2307():95-109. PubMed ID: 33847984
[TBL] [Abstract][Full Text] [Related]
5. Targeted Modulation of Chicken Genes In Vitro Using CRISPRa and CRISPRi Toolkit.
Chapman B; Han JH; Lee HJ; Ruud I; Kim TH
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107664
[TBL] [Abstract][Full Text] [Related]
6. Quantification of Genome Editing and Transcriptional Control Capabilities Reveals Hierarchies among Diverse CRISPR/Cas Systems in Human Cells.
Escobar M; Li J; Patel A; Liu S; Xu Q; Hilton IB
ACS Synth Biol; 2022 Oct; 11(10):3239-3250. PubMed ID: 36162812
[TBL] [Abstract][Full Text] [Related]
7. CRISPRi and CRISPRa Screens in Mammalian Cells for Precision Biology and Medicine.
Kampmann M
ACS Chem Biol; 2018 Feb; 13(2):406-416. PubMed ID: 29035510
[TBL] [Abstract][Full Text] [Related]
8. Maybe you can turn me on: CRISPRa-based strategies for therapeutic applications.
Becirovic E
Cell Mol Life Sci; 2022 Feb; 79(2):130. PubMed ID: 35152318
[TBL] [Abstract][Full Text] [Related]
9. Multi-layer CRISPRa/i circuits for dynamic genetic programs in cell-free and bacterial systems.
Tickman BI; Burbano DA; Chavali VP; Kiattisewee C; Fontana J; Khakimzhan A; Noireaux V; Zalatan JG; Carothers JM
Cell Syst; 2022 Mar; 13(3):215-229.e8. PubMed ID: 34800362
[TBL] [Abstract][Full Text] [Related]
10. Multiplex genome editing of microorganisms using CRISPR-Cas.
Adiego-Pérez B; Randazzo P; Daran JM; Verwaal R; Roubos JA; Daran-Lapujade P; van der Oost J
FEMS Microbiol Lett; 2019 Apr; 366(8):. PubMed ID: 31087001
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Enabled Tools for Engineering Microbial Genomes and Phenotypes.
Tarasava K; Oh EJ; Eckert CA; Gill RT
Biotechnol J; 2018 Sep; 13(9):e1700586. PubMed ID: 29917318
[TBL] [Abstract][Full Text] [Related]
12. CRISPR Interference (CRISPRi) and CRISPR Activation (CRISPRa) to Explore the Oncogenic lncRNA Network.
Morelli E; Gulla' A; Amodio N; Taiana E; Neri A; Fulciniti M; Munshi NC
Methods Mol Biol; 2021; 2348():189-204. PubMed ID: 34160808
[TBL] [Abstract][Full Text] [Related]
13. A CRISPR-dCas Toolbox for Genetic Engineering and Synthetic Biology.
Xu X; Qi LS
J Mol Biol; 2019 Jan; 431(1):34-47. PubMed ID: 29958882
[TBL] [Abstract][Full Text] [Related]
14. Overview of advances in CRISPR/deadCas9 technology and its applications in human diseases.
Kanafi MM; Tavallaei M
Gene; 2022 Jul; 830():146518. PubMed ID: 35447246
[TBL] [Abstract][Full Text] [Related]
15. Novel Prokaryotic CRISPR-Cas12a-Based Tool for Programmable Transcriptional Activation and Repression.
Schilling C; Koffas MAG; Sieber V; Schmid J
ACS Synth Biol; 2020 Dec; 9(12):3353-3363. PubMed ID: 33238093
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
Li C; Brant E; Budak H; Zhang B
J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas9 Genetic Analysis of Virus-Host Interactions.
Gebre M; Nomburg JL; Gewurz BE
Viruses; 2018 Jan; 10(2):. PubMed ID: 29385696
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-derived genome editing technologies for metabolic engineering.
Nishida K; Kondo A
Metab Eng; 2021 Jan; 63():141-147. PubMed ID: 33307189
[TBL] [Abstract][Full Text] [Related]
19. Dual direction CRISPR transcriptional regulation screening uncovers gene networks driving drug resistance.
le Sage C; Lawo S; Panicker P; Scales TME; Rahman SA; Little AS; McCarthy NJ; Moore JD; Cross BCS
Sci Rep; 2017 Dec; 7(1):17693. PubMed ID: 29255251
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/dCas system as the modulator of gene expression.
Kazi TA; Biswas SR
Prog Mol Biol Transl Sci; 2021; 178():99-122. PubMed ID: 33685602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
